XML 52 R45.htm IDEA: XBRL DOCUMENT
v3.26.1

Share Capital (Tables) | 3 Months Ended
--- | ---
Jun. 30, 2026
Equity [Abstract] |
Summary of Other Issuances and Share Capital Transactions | During the three months ended June 30, 2026, the Company had the following other issuances and share capital transactions:
|  | Number of common shares |  |  | Share capital |  |  | Share and warrant reserve |
Other issuances and share issue costs |  |  | - |  |  | $ | (571 | ) |  | $ | - |
Total |  |  | - |  |  | $ | (571 | ) |  | $ | - |
During the three months ended June 30, 2025, the Company had the following other issuances and share capital transactions:
|  | Number of common shares |  |  | Share capital |  |  | Share based reserve |
Other issuances and share issue costs |  |  | - |  |  | $ | (1,585 | ) |  | $ | - |
Total |  |  | - |  |  | $ | (1,585 | ) |  | $ | - |
Summary of Warrants | The following is a summary of the Company’s liability classified warrant activity during the three months ended June 30, 2026 and 2025:
|  | Number of whole warrants |  |  | Weighted average exercise price |  |  | Weighted average remaining life (years) |
Balance outstanding at March 31, 2026 |  |  | 30,838,728 |  |  | $ | 4.49 |  |  |  | 4.11 |
Issuance of warrants |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding at June 30, 2026 |  |  | 30,838,728 |  |  | $ | 4.58 |  |  |  | 3.87 |
|  | Number of whole warrants |  |  | Weighted average exercise price |  |  | Weighted average remaining life (years) |
Balance outstanding at March 31, 2025 |  |  | 12,133,150 |  |  | $ | 8.90 |  |  |  | 4.09 |
Issuance of warrants |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding at June 30, 2025 |  |  | 12,133,150 |  |  | $ | 8.41 |  |  |  | 3.84 |
The following is a summary of the Company’s liability classified warrant balances during the three months ended June 30, 2026 and 2025:
|  | Warrant derivative liability |
Balance outstanding at March 31, 2026 |  | $ | 27,522 |
Fair value change |  |  | (659 | )
Balance outstanding at June 30, 2026 |  | $ | 26,863 |
|  | Warrant derivative liability |
Balance outstanding at March 31, 2025 |  | $ | 8,647 |
Fair value change |  |  | 3,334 |
Balance outstanding at June 30, 2025 |  | $ | 11,981 |
(iv) Equity classified warrants The following is a summary of the Company’s equity classified warrant activity during the three months ended June 30, 2026 and 2025:
|  | Number of whole warrants |  |  | Weighted average exercise price |  |  | Weighted average remaining life (years) |  |  | Warrant reserve |
Balance outstanding at March 31, 2026 |  |  | 23,528,830 |  |  | $ | 4.08 |  |  |  | 3.46 |  |  | $ | 2,612,631 |
Issuance of warrants |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding at June 30, 2026 |  |  | 23,528,830 |  |  | $ | 4.08 |  |  |  | 3.21 |  |  | $ | 2,612,631 |
|  | Number of whole warrants |  |  | Weighted average exercise price |  |  | Weighted average remaining life (years) |  |  | Warrant reserve |
Balance outstanding at March 31, 2025 |  |  | 3,350,430 |  |  | $ | 16.18 |  |  |  | 4.12 |  |  | $ | 2,590,485 |
Issuance of warrants |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding at June 30, 2025 |  |  | 3,350,430 |  |  | $ | 16.18 |  |  |  | 3.87 |  |  | $ | 2,590,485 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity interest issued or issuable by acquirer as part of consideration transferred in business combination. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration